About Fluent BioSciences
Fluent BioSciences is a company based in Watertown (United States) founded in 2018 by Sepehr Kiani, Bill Hyun, Adam Abate, and Gary Zweiger was acquired by Illumina in July 2024.. Fluent BioSciences has raised $19 million across 2 funding rounds from investors including Illumina, NIH SBIR/STTR and Illumina Ventures. Fluent BioSciences offers products and services including PIPseeker Software and User Guide. Fluent BioSciences operates in a competitive market with competitors including GenScript, Neogen, Parse Biosciences, Sino Biological and Qiagen, among others.
- Headquarter Watertown, United States
- Founders Sepehr Kiani, Bill Hyun, Adam Abate, Gary Zweiger
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fluent BioSciences
Fluent BioSciences offers a comprehensive portfolio of products and services, including PIPseeker Software and User Guide. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Analyzes single cell RNA sequencing data and generates metrics.
Provides instructions for using PIPseeker software effectively.
Unlock access to complete
Unlock access to complete
Funding Insights of Fluent BioSciences
Fluent BioSciences has successfully raised a total of $19M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.7 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $1.7M
-
First Round
First Round
(01 Jun 2020)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Grant - Fluent BioSciences | Valuation |
investors |
|
| Jun, 2020 | Amount | Series A - Fluent BioSciences | Valuation | Illumina Ventures , Samsara BioCapital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Fluent BioSciences
Fluent BioSciences has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, NIH SBIR/STTR and Illumina Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Health tech startups are invested in by Illumina Ventures.
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided by Samsara BioCapital in California.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Fluent BioSciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Fluent BioSciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Fluent Biosciences Comparisons
Competitors of Fluent BioSciences
Fluent BioSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Neogen, Parse Biosciences, Sino Biological and Qiagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| domain | founded_year | HQ Location |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Fluent Biosciences
Frequently Asked Questions about Fluent BioSciences
When was Fluent BioSciences founded?
Fluent BioSciences was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Fluent BioSciences located?
Fluent BioSciences is headquartered in Watertown, United States.
Who is the current CEO of Fluent BioSciences?
Sepehr Kiani is the current CEO of Fluent BioSciences. They have also founded this company.
Is Fluent BioSciences a funded company?
Fluent BioSciences is a funded company, having raised a total of $19M across 2 funding rounds to date. The company's 1st funding round was a Series A of $19M, raised on Jun 01, 2020.
What does Fluent BioSciences do?
Fluent BioSciences was founded in 2018 and is headquartered in Watertown, United States. Operations focus on the biotechnology sector, where a proprietary reagent known as Pre-templated Instant Partitions (PIPs) is developed. This reagent facilitates the self-assembly of individual cells or molecules into uniform partitions for nucleic acid preparation. Applications include DNA and RNA sequencing as well as single-cell molecular analysis.
Who are the top competitors of Fluent BioSciences?
Fluent BioSciences's top competitors include Neogen, Sino Biological and Qiagen.
What products or services does Fluent BioSciences offer?
Fluent BioSciences offers PIPseeker Software and User Guide.
Who are Fluent BioSciences's investors?
Fluent BioSciences has 7 investors. Key investors include Illumina, NIH SBIR/STTR, Illumina Ventures, Samsara BioCapital, and Co-win Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.